Comparação de diferentes procedimentos de estimulação elétrica neuromuscular utilizados no tratamento da incontinência urinária de esforço feminina: ensaio clínico randomizado by ALVES, Priscila G. J. M. et al.
Original article
ISSN 1413-3555
Rev Bras Fisioter, São Carlos, v. 15, n. 5, p. 393-8, Sept./Oct. 2011
©Revista Brasileira de Fisioterapia
Comparison between two different 
neuromuscular electrical stimulation protocols 
for the treatment of female stress urinary 
incontinence: a randomized controlled trial
Comparação de diferentes procedimentos de estimulação elétrica 
neuromuscular utilizados no tratamento da incontinência urinária 
de esforço feminina: ensaio clínico randomizado
Priscila G. J. M. Alves1, Fabiana R. Nunes2, Elaine C. O. Guirro3
Abstract
Background: Neuromuscular electrical stimulation (NMES) is widely treatment for stress urinary incontinence (SUI) but there is no 
consensus in literature regarding the most effective treatment parameters. Objective: To compare two NMESintra-vaginal protocols for 
the treatment of SUI in women. Methods: The study included 20 volunteers with an average age of 55.55±6.51 years and with the clinical 
diagnosis of SUI. Volunteers were randomly divided into two groups: group 1 (G1) received NMES with medium-frequency current and 
group 2 (G2) received NMES with low-frequency current. Functional assessments of pelvic floor muscles (PFM) were performed by 
perineometry. The severity of signs and symptoms were objectively evaluated using the 1 hour pad test and subjectively evaluated 
using a visual analog scale that measured the discomfort caused by the SUI. Shapiro-Wilk test was used to analyze data normality, and 
the Friedman test was used to analyze nonparametric data. For analysis of symptoms related to SUI the Fisher exact test and the Mann-
Whitney test were used. Significance level of 5% was set for all data analysis. Results: No significant differences (p>0.05) were found 
between groups for any of the variable assessed. The within group analysis of initial and final evaluations (after NMES) demonstrated 
significant differences (p<0.05) in amount of urine lost, the discomfort caused by urinary incontinence and perineal pressure for both 
treatment groups. Conclusion: The two NMES protocols applied were equally effective in the treatment of SUI. 
Article registered in the Australian New Zealand Clinical Trials Registry (ANZCTR) under number ACTRN 12610000820000.
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Resumo
Contextualização: A estimulação elétrica neuromuscular (EENM) é amplamente utilizada no tratamento da incontinência urinária de esforço 
(IUE), no entanto não há consenso na literatura sobre os parâmetros de tratamento mais eficazes. Objetivo: Avaliar os procedimentos de EENM 
intravaginal no tratamento de mulheres com IUE. Métodos: Participaram do estudo 20 voluntárias com idade média de 55,55±6,51 anos, com 
diagnóstico clínico de IUE. As voluntárias foram divididas aleatoriamente em dois grupos: grupo 1 (G1), que recebeu EENM com corrente 
de média frequência, e grupo 2 (G2), com corrente de baixa frequência. A avaliação funcional dos músculos do assoalho pélvico (MAP) foi 
realizada por meio de perineometria, e a severidade dos sinais e sintomas da IUE foi avaliada, objetivamente, pelo pad test de uma hora e, 
subjetivamente, pela Escala Visual Analógica (EVA), que mediu o desconforto causado pela incontinência. Para a análise de normalidade dos 
dados, utilizou-se o teste Shapiro-Wilk, seguido do teste de Friedman para dados não paramétricos. Para a análise dos sintomas relacionados 
à IUE, usaram-se os testes Exato de Fisher e Mann-Whitney. Em todas as análises, considerou-se o nível de significância de 5%. Resultados: 
Não houve diferença significativa (p>0,05) entre os grupos em nenhuma variável avaliada. Na comparação intragrupos das avaliações iniciais e 
finais (após EENM), houve diferença significativa (p<0,05) na quantidade de urina perdida, no desconforto causado pela incontinência urinária 
e na pressão perineal. Conclusão: Os procedimentos de EENM utilizados neste estudo foram igualmente eficazes no tratamento da IUE.
Artigo registrado no Australian New Zealand Clinical Trials Registry (ANZCTR) sob o número ACTRN 12610000820000.
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Introduction  
Urinary incontinence (UI) which is the involuntary loss 
of urine has high prevalence and represents a major public 
world wide health problem that can be associated with 
social isolation affecting quality of life1,2. It is estimated that 
approximately 200 million people around the world suffer 
from some form of UI2.
Stress urinary incontinence (SUI) is the most common 
type of UI and is defined as involuntary loss of urine that 
occurs when the intra-abdominal pressure and consequently 
the intravesical pressure exceeds maximum urethral closure 
pressure. Therefore, SUI commonly occurs during efforts, 
such as coughing, sneezing, laughing, jumping, running and 
lifting weight1,2.
The etiology of SUI is multifactorial with the most common 
cause being dysfunctions of the pelvic floor muscles (PFM). 
Therefore, several factors associated with pelvic floor muscles 
dysfunction have been reported to brisk factors for the condition 
such as pregnancy, types of delivery, parity, anatomical 
abnormalities of the urethra, nerve conduction disturbance 
in the PFM, genetic predisposition, iatrogenic causes resulting 
from surgery, age, estrogen level drop during menopause, and 
increased intra-abdominal pressure3,4. The normal function 
of the PFM is essential for supporting the pelvic visceras and 
maintaining urinary continence5,6.
Considering that the most common cause of stress 
incontinence is weakness of the PFM, available treatments, 
conservative or not, are aimed at rectifying this problem. 
However, surgical interventions have been reported to have 
low success rates and to be associated with postoperative 
complications and deterioration of clinical status. As a result 
of the poor outcomes of surgical treatments and with evidence 
suggesting positive results of conservative treatments with few 
adverse events, conservative treatment has been considered 
the first line of care for the treatment of SUI5.
The most common for of conservative treatment for stress 
urinary incontinence are PFM exercises, biofeedback, vaginal 
cones, electrical and magnetic stimulation. Neuromuscular 
electrical stimulation (NMES) aims to strengthen the PFM in an 
attempt to recover urinary continence mechanisms7,8. Although 
used successfully for over 25 years in clinical practice, there 
has been no consensus regarding the most effective treatment 
parameters and protocols of electrical stimulation. Previous 
studies evaluating the effectiveness of NMES reported varying 
protocols with regards to the location of the electrode (anal, 
vaginal or superficial), current parameters, time and duration 
of treatment8,9. The currents of low frequency (LF - 50 Hz) and 
low average frequency modulated (FM - 2000 Hz, modulated 
at 50 Hz) were predominantly used for the treatment of SUI in 
previous studies7,9-13.
Medium frequency currents spread rapidly through the tissues 
arriving at the motor threshold easier and more comfortably 
than low frequency currents due to the lower impedance offered 
to theshort electrical pulses. Therefore, the use of medium 
frequencies allows for the use of a wider range of currents with 
recruitment of more motor units and penetration into deeper 
tissues without causing discomfort for the volunteers. As 
recommended, the maximum possible intensity for short periods 
of treatment should be applied, which is already commonly 
performed in clinical practice. At the same time, MF NMES 
stimulates nerves due to amplitude modulation which allows 
the current to develop the same electrophysiological responses 
in cells and tissues as that of therapeutic LF currents14-17.
Based on the  aforementioned and given the lack of 
standardization of electrical parameters in the treatment of 
female SUI, the objective of this study was to evaluate two 
parameters of intravaginal NMES low and medium frequencies, 
for the treatment of women with SUI.
Methods  
Twenty four volunteers were included in this randomized 
controlled trial; however, only 20 were included in our 
results as 4 patients failed to complete treatments. Patients’ 
age was between 42 and 64 years (55.55±6.51), body mass 
index (BMI) between 22.48 and 37.81 kg/m2 (28.66±5.49). All 
patients had a clinical diagnosis of SUI and urinary loss for 
at least three months.
The exclusion criteria was: urogenital prolapse grade III 
or higher18, urinary tract infection, instability of the detrusor 
muscle, cardiac pacemakers, devices implanted in the 
pelvis, vaginal inflammation/infections, pregnancy, intrinsic 
sphincter deficiency, use of hormone replacement therapy, 
pelvic or abdominal surgery within the last six months, 
cognitive impairment and non-attendance of the number of 
sessions provided.
The volunteers were randomly divided into two distinct 
groups, 10 women received NMES with a MF current (G1) and 
10 women received NMES with a LF current (G2). The average 
age of group of G1 was 55.70±7.17 years and of group G2 was 
55.40±6.98 years.
The study was conducted in accordance with the resolution 
196/96 of the National Health Council (CNS). The research was 
approved by the Ethics Committee of the Universidade Metodista 
de Piracicaba (UNIMEP), Piracicaba, SP, Brazil, under Protocol 
44/06, and all women signed an informed consent form.
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The initial evaluation was conducted through individual 
interviews using a questionnaire to verify personal data, 
lifestyle, personal history, medication, gynecological history 
and obstetric characteristics of the symptoms of urinary leakage 
at the initial stages, quantity, frequency and circumstances 
of urinary loss, urinary disorders (nocturia, urgency, dysuria, 
etc.) and the need or use of guards (pads). Volunteers were 
instructed to register their daily urinary frequency using a 
diary for seven days before and after treatment.
A pulse generator 961 Dualpex® (QUARK®) with two 
independent channels were used for NMES. The volunteers were 
positioned in supine with the legs flexed and abducted. NMES 
was performed via intravaginal electrode previously cleaned 
and inserted with intimate lubricant gel in the vaginal canal for 
20 minutes at maximum tolerable intensity twice a week for six 
weeks adding to a total of 12 sessions. The following electrical 
parameters were used: Group 1 (G1): medium frequency (MF) 
current, biphasic frequency of 2000 Hz, pulse width of 100 ms, 
time on: off 4:8 s, and modulation frequency of 50 Hz; Group 
2 (G2): low frequency (LF) current, biphasic, 50 Hz frequency, 
pulse width of 700 ms, time on: off 4:8 s.
The perineal pressure was measured at six different times: 
before the first session (PRE), after the fourth (POST 4), sixth 
(POST 6), eighth (POST 8), tenth (POS 10) and twelfth (POST 
12) NMESsession. The perineometry was performed with 
the equipment MyofeedbackPneumátco – PERINA 966-2, 
QUARK® (ANVISA registration No. 80079190005), graded from 
0 to 46.4 mmHg, and calibrated by the Office of Weights and 
Measures (IPEM). The probe was coated with urogynecologic 
sterile non-lubricated condom (brand Blowtex®) and covered 
by intimate lubricant gel KY® ( Johnson & Johnson).
The test for PFM maximum voluntary contraction was 
performed with  volunteers positioned in supine with hips 
flexion of approximately 60° and knee flexion of approximately 
45°. We conducted initial awareness training for the maneuvers 
to be performed for identification of PFM contraction. A four 
second maximum sustained contraction of the muscles  was 
elicited with the aid of verbal commands (“squeeze, squeeze, 
squeeze”) always given by the same researcher. Contraction of 
the PFM was considered valid only if simultaneous observable 
cranial movement of the perineum occured19. The procedure 
was repeated three times with an interval of 60s. All evaluations 
of the pelvic floor were made by the same investigator 
throughout the study.
An objective assessment of urinary incontinence was 
carried out using a 1 hour pad test, witch according to the 
study of Liebergall-Wischnitzer et al.20 provide similar results 
as subjective evaluation tools of urinary incontinence. The pad 
test was performed at: PRE, POST 6 and POST 12 NMES session. 
To evaluate the severity of urinary incontinence, the results of 
the pad test were categorized according to the Laycock and 
Green14 criteria.
A visual analog scale (VAS) was used at PRE, POST 6 
and POST 12 to subjectively evaluate the discomfort caused 
by urinary incontinence. The scale consisted of a 10 cm line 
ranging from “no discomfort” to “very uncomfortable”.
Data analysis
The sample size was previously calculated based on 
averages and standard deviations of perineal pressure obtained 
from a pilot study. The result demonstrated the need to include 
20 volunteers for a test power of 80% with alpha significance 
level of 0.05 (software GraphpadStatemate 2.0®).
For analysis of data normality, we used the Shapiro-Wilk 
test, followed by the Friedman test for nonparametric data. 
For analysis of symptoms related to UTI, as well as the history 
of the volunteers the Fisher exact test and the Mann-Whitney 
test were used. The data recorded in the diary was analyzed 
using the Wilcoxon test and Mann-Whitney tests for within 
and between groups analysis, respectively. The intra-therapist 
agreement (within-session) for the PFM assessments was 
evaluated using the kappa statistic, considering negligible 
agreement for kappa between 0 and 0.2, median agreement 
between 0.21 and 0.4, moderate agreement between 0.41 and 
0.6, substantial agreement between 0.61 and 0.8, and almost 
perfect agreement between 0.81 and 1.0, according to the 
criteria of Landis and Koch21. A significance level of 5% was used 
for all data analysis. All statistical procedures were performed 
using Bioestat 4.0.
Results  
There were no significant differences (p>0.05) of age and 
BMI between groups characterizing a homogeneous sample. 
The intra-therapist agreement (within-session) for the PFM 
assessments was substantial with kappa of - 0.6121.
The average time from onset of complaints of stress 
urinary incontinence was not significant different (p>0.05) 
between groups (G1=6.50±7.95 years and G2=7.20±6.03 years. 
The average urinary frequency that was evaluated using a 
diary for seven days demonstrated urination of 6.80±1.72 for 
G1 and 8.54±2.98 urination for G2 at PRE (p>0.05). A within 
group significant difference was observed between pre and 
post treatment values for G1 and G2, but no significant 
difference (p>0.05) were found between groups at POST 
(G1 – 5.55±1.37 and G2 – 5.80±2.00 urination), demonstrating 
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a reduced frequency of micturition after treatment in both 
groups.
The objective evaluation of urine loss (in grams) using the 
1-hour pad test demonstrated similar average urinary loss 
at PRE for G1 and G2 (p>0.05), indicating that both groups 
suffered from mild to moderate urinary incontinence according 
to the criteria of Laycock and Green14. There were statistically 
significant (p<0.05) within groups differences for the values 
of PRE and POST 12 for both groups. The amount of leakage 
in the 1-hour pad test for the within group differences for 
Classification
G1 G2
PRE POS 6 POS 12 PRE POS 6 POS 12
Drought (lossless) 0 90% 100% 0 40% 100%
Mild to moderate loss 90% 10% 0 90% 60% 0
Severe loss 10% 0 0 10% 0 0
Table 1. Distribution of the volunteers according to the classification 
of the severity of urinary incontinence categorized according to criteria 
of Laycock and Green14, before the first session (PRE), after sixth (POST 
6) and twelfthsessions (POST 12) of NMES with medium frequency (G1) 
and low frequency current (G2).
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Figure 1. Pad urine loss of urine before the first test (PRE), after the 
sixth (POST 6) and twelfth session (POST 12) of NMES with medium 
frequency (G1) and low frequency current (G2).
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Figure 2. Perineal pressure (mmHg) before (PRE), after fourth (POST 
4), sixth (POST 6), eightieth (8 POST), tenth (POST 10) and twelfth 
sessions (POST 12) treatment with NMES medium frequency (G1).
Figure 3. Perineal pressure (mmHg) before (PRE), after fourth (POST 
4), sixth (POST 6), eightieth (8 POST), 10 (POST 10) and twelfth 
sessions (POST 12) treatment with NMES low frequency (G2).
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PRE and POST 6 and between POST 6 and POST 12 were not 
significantly different (p>0.05) for both groups. These results 
demonstrate that there was a gradual decrease in urinary 
loss in both groups with this decrease becoming significant 
only after the last treatment session. There was no significant 
difference (p>0.05) in urine loss between groups at any of the 
follow-ups (Figure 1).
There were no significant difference (p>0.05) between groups 
at PRE, POST 6 and POST 12 for the objective evaluation of urine 
loss according to the criteria of Laycock and Green14 (Table 1).
The mean degree of discomfort of the UI symptoms assessed 
using VAS was 7.4±1.8 at PRE, 3.3±1.5 at POST6 and 0.6±0.7cm 
at POST12 for G1 and 7.2±1.8 cm at PRE, 3.2±1.4 cm at POST6 
and 0.5±0.4 cm at POST12 for G2. There were no significant 
difference between groups for any of the follow-ups (p>0.05). 
There were within group significant differences for both G1 
and G2 between PRE and POST 12 (p<0.05). 
The perineal pressure was not signicantly different 
(p>0.05) between G1 and G2. However, the within group 
comparisons were significantly different between PRE and 
POST 8, 10 and 12 and POST4 with POST10 and 12 for both 
groups (Figures 2 and 3).
Discussion  
Amaro, Gameiro and Padovani5 observed reduction 
in voiding frequency of 7 to 5.5 micturition per day after 
treatment with LF intravaginal NMES current with the 
addition of perineal exercises 5 weeks after beginning of NMES 
in volunteers suffering from UI. Similar results were observed 
in this study where the average urination was 6.80±1.72 at PRE 
and 5.55±1.37 at POST treatment in G1 and 8.54±2.98 at PRE 
and 5.80±2.00 urination at POST treatment in G2.
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In relation to the objective assessment of the amount of 
urine lost and the severity of symptoms assessed by the 1 hour 
pad test in both groups there was a decreased amount of urine 
lost and consequently an improvement in the degree of severity 
of UI over the six weeks of treatment. This data agrees with 
findings by Oláh et al.15 who compared the use of vaginal cones 
to the use of MF NMES current in a group of women with UI. 
After four weeks of treatment, 50% of volunteers in the cone 
group and 76% in the NMES group had improvements in the 
1-hour pad test. Similarly, on the studies of Castro et al.22 and 
Santos et al.23 there were a reduction of urinary loss in the pad 
test in women with UI who underwent LF NMES, exercises for 
the PFM or vaginal cone therapy. 
Laycock and Jerwood16 treated incontinent women with 
MF NMES current modulated at low and NMES placebo and 
found significant improvements in the values of the modified 
pad test among women who received the active current. 
Amaro, Gameiro and Padovani5 using NMES associated with 
perineal exercises found significant reduction in the amount of 
urine lost after treatment.
Parkkinen et al.11 using MF NMES current after an exercises 
series for the PFM associated with biofeedback to treat women 
with stress incontinence observed a significant reduction 
in urinary loss from a 1 hour pad test after four months of 
treatment and follow-ups of 12 months and 5 years. However, 
there was no significant difference between women who 
received PFM exercises associated to biofeedback and NMES 
from those who received PFM exercises only.
Sand et al.9 in a clinical double-blind study treated 52 
women with SUI during 15 weeks divided into two groups: 
one using an equipment of active NMES at frequencies of 
12.5 Hz and 50 Hz simultaneously and one of NMES placebo 
(SHAM). The reduction in urine loss during on the modified 
20 minutes pad test in women with active devices was better 
than those from the SHAM group. Similarly, Yamanishi et al.24 
found a significant reduction in urine loss on a 1 hour pad 
test in the group of active device compared with the SHAM 
device group. In the present study, all women from G1 and G2 
were considered cured25 after six weeks of treatment, i.e. no 
urine loss. However, the studies of Luber and Wolde-Tsadik26 
and Spruijt et al.27 using the pad test showed no significant 
difference in urine loss in women with SUI treated with 
NMES compared with the control group (placebo NMES) or 
Kegel exercises.
Richardson et al.13 observed significant improvement 
in VAS values after the use of LF NMES current either 
daily or on alternate days but with no difference between 
the two regimes. Miller et al.28 aiming to determine the 
number of sessions necessary for a NMES treatment found 
a reduction in complaints of discomfort from 10 weeks of 
treatment. However, on the present study the complaints 
of discomfort had not yet significantly reduced after six 
weeks of treatment. Demirtürk et al.29 noted improvement 
in signs and symptoms of stress incontinence after 5 weeks 
of treatment with 15 min of electrical stimulation, three 
times a week, but the parameters of electrical stimulation 
used were not clearly described.
In a study by Sand et al.9 the results of the VAS were 
significantly greater in volunteers who used an active 
device than from those who received a placebo (SHAM 
group). Laycock and Jerwood16 demonstrated a significant 
improvement in VAS after the application of NMES with an 
interferential current and no effect on the NMES group using 
placebo. The same was also described by Bø, Talseth and 
Holme30 who compared women that underwent LF NMES 
current and a no treatment group.
The perineometry of PFM in this study showed significant 
growth after the eighth treatment session in both groups, 
confirming the results found in other studies5,30.
Sand et al.9 found a significant increase in perineal pressure 
among women who used active NMES compared to NMES 
placebo current. However, Amaro, Gameiro and Padovani5 
found no statistical difference in perineal pressure among 
groups after one month of treatment, using a current of 4 Hz 
and pulse width of 0.1 μs.
Muscle contraction caused by NMES is directly influenced 
by amplitude and pulse width. Parkkinen et al.11 have 
recommended an interferential current with a frequency 
of 2000 Hz, modulated at 50 Hz and a pulse width of 250 μs. 
Laycock and Jerwood16 have recommended frequencies of 
35-40 Hz and a pulse width of 250 μs as effective and tolerable 
for women, while other authors have recommend a frequency 
of 50 Hz and pulse width of 300 μs9,13.
Bø and Maanum10 investigated whether the electrically 
induced contraction of PFM was similar to that of voluntary 
contraction. They used two NMES devices with different pulse 
widths (500 μs and 750 μs) and frequencies of 10 Hz, 20 Hz 
and 50 Hz, which were matched, making five combinations 
of electrical parameters: 10 Hz and 750 μs, 20 Hz and 750 μs, 
50 Hz and 750 μs, 10 Hz and 500 μs and 50 Hz of frequency 
and 500 μs of pulse width. The results showed that only one 
woman reported feeling PFM contraction using 50 Hz, pulse 
width of 500 μs and intensity of 30 mA. The other electrical 
currents caused discomfort, pain, sensations and movements 
from different physiological voluntary contraction. Moreover, 
the tolerance levels of intensity (on a scale of 0 to 10 where 0 is 
the “minimum” and 10 “maximum”) were lower when subjects 
underwent the currents with pulse widths of 750 μs.
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Although rare, some studies reported adverse events such 
as pain, discomfort, irritation and vaginal infections with 
the use of NMES7,9,10. However, in this study, NMES was well 
received by the volunteers.
The current study presents a limitation regarding the  lack 
of follow-up to access whether the improvements achieved 
with the different parameters of electrical stimulation would 
last in the long term.
Based on these results, it can be inferred that the LF and 
MF NMES were similarly effective in the treatment of female 
SUI, generating increased perineal pressure, reduced urinary 
loss and symptoms related to UI.
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